Vaccines containing long HPV peptides recently emerged as a promising therapeutic modality for HPV-related cancers, as these long peptides proved capable of increasing the number and activity of HPV-16-specific CD4 and CD8 T cells [32, 33]. This evidence concerns the gene CD8A and cancer.